Eli Lilly said its sees growth from key treatments such as Trulicity, Taltz and Verzenio driving 2021 revenues to around $28 billion. Eli Lilly said 2020 revenues should come in between $24.2 ...
Eli Lilly said sales of its blockbuster diabetes treatment, Trulicity, rose 20% from last year to $1.23 billion, but overall revenues missed analysts' forecasts. Eli Lilly & Co. (LLY) posted ...
Eli Lilly (NYSE: LLY) saw its net income decline by $1 billion or 16% y-o-y to $5.2 billion in 2023. This can primarily be attributed to higher acquired in-process research and development ...
Eli Lilly 's ( LLY -0.55%) name has become somewhat synonymous with its work in diabetes and obesity care. That's ...
Deep-pocketed investors have adopted a bullish approach towards Eli Lilly and Co LLY, and it's something market players ...
Eli Lilly was a Union Army Civil War veteran and chemist who founded the company that bears his name in 1876. Eli Lilly & Co.
Eli Lilly and Company LLY posted mixed first-quarter 2024 earnings, beating earnings estimates but lagging on revenues. The pharmaceutical giant raised its outlook for 2024 on rapidly climbing ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.
Eli Lilly has doubled its investment in its new Concord manufacturing facility from $1 billion to $2 billion since ...
Eli Lilly and Co. (NYSE: LLY) more than doubled its initial investment pledge for its $2 billion Concord manufacturing campus ...
Eli Lilly (LLY) is one step closer to getting its new Alzheimer's treatment approved by the Food and Drug Administration (FDA) after a panel voted to recommend its use. BMO Capital Markets ...
Eli Lilly has more work it wants to do with the hard-won success from its weight loss and diabetes drugs, Zepbound and ...